Company Overview
Nutex Health Inc. functions as a healthcare services and operations entity within the United States, utilizing a diversified model that spans hospital development and operations, population health management, and real estate holdings. The company is positioned within the Healthcare sector, specifically under the Medical Care Facilities industry, a classification that denotes its primary revenue generation stems from delivering direct patient care and managing facility infrastructure rather than pharmaceuticals or insurance. As of the latest data, Nutex Health Inc. holds a market capitalization of $614.51M and generates annual revenue of $875.26M, supported by an organizational structure employing 944 individuals. These valuation and revenue figures indicate a mid-sized enterprise operating with significant scale within the domestic healthcare market, suggesting substantial asset bases and operational complexity. The presence of 944 employees across its segments implies a labor-intensive business model typical of facility-based healthcare providers, while the $875.26M revenue stream reflects a robust ability to monetize its network of micro hospitals, specialty hospitals, and population health initiatives.
Financial Health
Nutex Health Inc. reported a Trailing Twelve Months (TTM) revenue of $875.26M with a corresponding net income of $70.79M and an EBITDA of $413.16M. The substantial disparity between the $875.26M revenue and the $70.79M net income reveals a cost structure where operational expenses, including the wages of 944 employees and facility maintenance, consume the majority of top-line revenue, leaving a compressed net profit margin. Despite the lower net income, the company generates significant Free Cash Flow of $152.81M, which indicates a strong capacity to fund capital expenditures, repay debt, or pursue strategic acquisitions without relying on external equity financing. The company maintains a cash balance of $185.57M against total debt of $351.39M, resulting in a Debt to Equity ratio of 82.99, which characterizes a highly leveraged balance sheet where interest obligations are significant relative to equity capitalization. Liquidity is supported by a Current Ratio of 3.41, a metric that signifies the company possesses more than three times the current assets necessary to cover its short-term liabilities, providing a comfortable buffer against immediate financial obligations. Efficiency and profitability are further highlighted by a Return on Equity of 58.9% and a Return on Assets of 31.2%, metrics that demonstrate management effectiveness in generating substantial returns despite the heavy debt load.
Valuation Assessment
The stock carries a P/E Ratio (TTM) of 8.29 and a Forward P/E of 4.27, a significant divergence that implies the market expects a sharp contraction in earnings or a re-rating of the stock price in the future to align with current valuation multiples. The Price to Book ratio stands at 1.87, indicating that the market values the company at a 87% premium over its net asset value, which can be attributed to the intangible value of its hospital network and real estate assets. Alternative valuation metrics such as a Price to Sales ratio of 0.70 and an EV/EBITDA of 2.13 suggest the stock is priced very cheaply relative to its sales and earnings power, though this low multiple must be viewed in the context of the recent earnings decline. The 52-week trading range spans from a low of $45.88 to a high of $193.07, meaning the current market price sits significantly below the 52-week high, reflecting recent volatility and investor sentiment shifts. The Beta of 2.00 indicates that the stock's price volatility is twice as high as the broader market, exposing investors to substantial price swings during periods of market turbulence.
Growth & Income
Nutex Health Inc. experienced a Revenue Growth (YoY) of -41.1% and an Earnings Growth (YoY) of -86.2%, demonstrating that earnings are declining at a much faster rate than revenue. This disproportionate decline suggests that the drop in profitability is driven by factors beyond simple revenue contraction, such as fixed cost structures or one-time expenses that disproportionately impact the bottom line while top-line sales face a separate headwind. As a non-dividend payer, the company has a Dividend Yield of N/A and a Payout Ratio of 0.0%, confirming that all available earnings are retained within the business rather than distributed to shareholders. Consequently, the company reinvests its capital back into operations, likely funding the maintenance of its real estate segments or the expansion of its population health management initiatives. The overall growth and income profile is currently defined by contraction in both revenue and earnings, with no distribution of income to investors, creating a scenario where shareholder value relies entirely on future operational improvements or asset appreciation rather than current cash distributions.